ICD Code C50.912

ICD code C50.912 is a classification used to identify a malignant neoplasm, or cancerous tumor, located in an unspecified site of the left female breast. This code is part of the International Classification of Diseases (ICD) system, which is used by healthcare providers to standardize the diagnosis of diseases and conditions for billing and record-keeping purposes. The "unspecified site" indicates that the exact location within the left breast where the cancer is present has not been detailed in the medical documentation.

When using the ICD code for a malignant neoplasm of an unspecified site of the left female breast, healthcare providers should consider the following diagnostic criteria and symptoms:

1. Presence of a Tumor: Identification of a mass or lump in the left breast through physical examination or imaging studies such as mammography or ultrasound.

2. Histopathological Confirmation: Biopsy results confirming malignancy, indicating cancerous cells in the breast tissue.

3. Unspecified Site: Inability to determine the exact location within the left breast where the neoplasm originates, despite diagnostic imaging or examination.

4. Clinical Symptoms: Observation of symptoms such as changes in breast size or shape, skin dimpling, nipple discharge, or inversion, which are indicative of breast cancer.

5. Patient History: Consideration of the patient's medical history, including any previous breast cancer diagnoses, family history of breast cancer, or genetic predispositions.

6. Additional Diagnostic Tests: Utilization of further diagnostic tests, such as MRI or PET scans, to assess the extent of the disease and rule out metastasis.

7. Exclusion of Benign Conditions: Ruling out benign breast conditions such as fibroadenomas or cysts through clinical evaluation and diagnostic testing.

By adhering to these criteria, healthcare providers can accurately apply the ICD code for malignant neoplasm of an unspecified site of the left female breast, ensuring appropriate documentation and treatment planning.

For the ICD code C50.912, which pertains to a malignant neoplasm of an unspecified site of the left female breast, the relevant CPT codes that may be applicable include:

1. 19120 - Excision of cyst, fibroadenoma, or other benign or malignant tumor, aberrant breast tissue, duct lesion, nipple or areolar lesion; open, one or more lesions.

2. 19301 - Mastectomy, partial (e.g., lumpectomy, tylectomy, quadrantectomy, segmentectomy).

3. 19302 - Mastectomy, partial (e.g., lumpectomy, tylectomy, quadrantectomy, segmentectomy); with axillary lymphadenectomy.

4. 19303 - Mastectomy, simple, complete.

5. 19305 - Mastectomy, radical, including pectoral muscles, axillary lymph nodes.

6. 19307 - Mastectomy, modified radical, including axillary lymph nodes, with or without pectoralis minor muscle, but excluding pectoralis major muscle.

7. 38525 - Biopsy or excision of lymph node(s); open, deep axillary node(s).

8. 38792 - Injection procedure; for identification of sentinel node.

9. 76098 - Radiological examination, surgical specimen.

10. 77067 - Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (CAD) when performed.

These CPT codes are commonly associated with procedures that may be performed for the diagnosis, treatment, or management of breast cancer. It is important to verify the specific procedures and services provided to ensure accurate coding and billing.

Discover how MD Clarity's RevFind software can enhance your revenue cycle management by accurately reading your contracts and detecting underpayments for CPT codes associated with ICD code C50.912. Schedule a demo today to see how RevFind can ensure you're receiving the full reimbursement you deserve.